These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 109541)

  • 1. Studies on the terminal stages of immune hemolysis. VI. Osmotic blockers of differing Stokes' radii detect complement-induced transmembrane channels of differing size.
    Boyle MD; Gee AP; Borsos T
    J Immunol; 1979 Jul; 123(1):77-82. PubMed ID: 109541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the terminal stages of immune hemolysis. V. Evidence that not all complement-produced transmembrane channels are equal.
    Boyle MD; Borsos T
    J Immunol; 1979 Jul; 123(1):71-6. PubMed ID: 109540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the terminal stages of immune hemolysis. IV. Effect of metal salts.
    Boyle MD; Langone JJ; Borsos T
    J Immunol; 1979 Apr; 122(4):1209-13. PubMed ID: 448086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of complement-induced cell lysis. Demonstration of a three-step mechanism of EAC1-8 cell lysis by C9 and of a non-osmotic swelling of erythrocytes.
    Valet G; Opferkuch W
    J Immunol; 1975 Oct; 115(4):1028-33. PubMed ID: 809505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructure of membrane lesions in immune lysis, osmotic lysis and drug-induced lysis.
    Seeman P
    Fed Proc; 1974 Oct; 33(10):2116-24. PubMed ID: 4607618
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between channel size and the number of C9 molecules in the C5b-9 complex.
    Ramm LE; Whitlow MB; Mayer MM
    J Immunol; 1985 Apr; 134(4):2594-9. PubMed ID: 2579147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W; Stankiewicz M
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):451-60. PubMed ID: 3099725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modifications of the final stages of the complement reaction by alkali metal cations.
    Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
    J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel.
    Boyle MD; Langone JJ; Borsos T
    J Immunol; 1978 May; 120(5):1721-25. PubMed ID: 659873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deviated lysis (d.l.): III. Kinetics of interaction of d.l. activity with chicken erythrocytes: evidence for E formation.
    Borsos T; Rother U
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):36-47. PubMed ID: 405812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the terminal stages of antibody-complement mediated killing of a tumor cell. III. Effect of membrane active agents.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 Jul; 117(1):106-9. PubMed ID: 932422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of various compounds on lysis of antibody-coated sheep erythrocytes by hypotonic shock or complement.
    Müller-Peddinghaus R; Erdtmann K
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):287-92. PubMed ID: 6748820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell volume and osmotic properties of erythrocytes after complement lysis measured by flow cytometry.
    Bauer J; Valet G
    J Immunol; 1983 Feb; 130(2):839-44. PubMed ID: 6848597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of morphological response of red cells in a sucrose solution.
    Rudenko SV
    Blood Cells Mol Dis; 2009; 42(3):252-61. PubMed ID: 19249232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deviated lysis: lysis of unsensitized cells by complement. V. Generation of the activity of low pH or low ionic strength.
    Rother U; Hänsch G; Rauterberg EW; Jungfer H; Rother K
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):118-29. PubMed ID: 34275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional size of the primary complement lesion in resealed erythrocyte membrane ghosts.
    Giavedoni EB; Chow YM; Dalmasso AP
    J Immunol; 1979 Jan; 122(1):240-5. PubMed ID: 570203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.